Salon professionals in New York, including Ashley DiMatteo and Briana Delvecchio, have noted a growing trend of temporary hair loss among patients using GLP-1 drugs. These medications, primarily prescribed for weight management and diabetes, are associated with weight loss that can lead to a condition known as telogen effluvium. Delvecchio explained that hair loss typically appears 2-3 months after starting the medication, often resulting in noticeable thinning. DiMatteo added that while the condition is usually temporary, it can be distressing for patients who were not anticipating this side effect. The professionals recommend that individuals using GLP-1 drugs consult with their healthcare providers to monitor any changes in hair growth patterns.